Search Results - "Thomas P. Blackburn"

Refine Results
  1. 1
  2. 2

    Depressive disorders: Treatment failures and poor prognosis over the last 50 years by Blackburn, Thomas P.

    Published in Pharmacology research & perspectives (01-06-2019)
    “…Depression like many diseases is pleiotropic but unlike cancer and Alzheimer's disease for example, is still largely stigmatized and falls into the dark…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years? by Hainsworth, Atticus H, Blackburn, Thomas P, Bradshaw, Elizabeth M, Elahi, Fanny M, Gorelick, Philip B, Isaacs, Jeremy D, Wallin, Anders, Williams, Steven CR

    “…•In the past twenty years molecular science has delivered progress in therapeutic antibodies, biochemical markers, gene therapy and drug re-purposing.•Areas of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids by Bäckström, Torbjörn, Turkmen, Sahruh, Das, Roshni, Doverskog, Magnus, Blackburn, Thomas P.

    Published in Journal of internal medicine (01-09-2023)
    “…The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging…”
    Get full text
    Journal Article
  8. 8

    Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment by Bäckström, Torbjörn, Doverskog, Magnus, Blackburn, Thomas P., Scharschmidt, Bruce F., Felipo, Vicente

    Published in Neuroscience and biobehavioral reviews (01-06-2024)
    “…Neuroinflammation accompanies several brain disorders, either as a secondary consequence or as a primary cause and may contribute importantly to disease…”
    Get full text
    Journal Article
  9. 9

    Selecting Double Bond Positions with a Single Cation-Responsive Iridium Olefin Isomerization Catalyst by Camp, Andrew M, Kita, Matthew R, Blackburn, P. Thomas, Dodge, Henry M, Chen, Chun-Hsing, Miller, Alexander J. M

    Published in Journal of the American Chemical Society (24-02-2021)
    “…The catalytic transposition of double bonds holds promise as an ideal route to alkenes of value as fragrances, commodity chemicals, and pharmaceuticals; yet,…”
    Get full text
    Journal Article
  10. 10

    Effects of a triangular nanocage structure on the binding of neutral and anionic ligands to CoII and ZnII porphyrins by Blackburn, P. Thomas, Lipke, Mark C.

    Published in Journal of coordination chemistry (28-10-2022)
    “…Interactions of neutral pyridine ligands and anionic benzoate ligands with the metalloporphyrin walls of M 6 L 3 nanocages (M = [(tmeda)Pt] 2+ , L =…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    In memory of Norman Bowery (1944–2016) by Trist, David G, Kenakin, Terry P, Blackburn, Thomas P

    Published in Current opinion in pharmacology (01-08-2017)
    “…•An article in memory of Professor Norman Bowery.•Norman Bowery discovered the GABAB receptor.•He identified the mechanism of action of Baclofen as a GABAB…”
    Get full text
    Journal Article
  14. 14

    The medical benefit of 5-HT research by Jones, Brian J, Blackburn, Thomas P

    Published in Pharmacology, biochemistry and behavior (01-04-2002)
    “…5-HT research is now more than 50 years old, and it has generated a wealth of therapeutic agents, some of which have had a major impact on disease management…”
    Get full text
    Journal Article
  15. 15

    Trace amine receptors as targets for novel therapeutics: legend, myth and fact by Branchek, Theresa A, Blackburn, Thomas P

    Published in Current opinion in pharmacology (01-02-2003)
    “…Trace amines are attracting attention as neurotransmitters because they are believed to play a role in human disorders such as schizophrenia, depression,…”
    Get full text
    Journal Article
  16. 16

    Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study by Sekine, Yoshimoto, Suzuki, Katsuaki, Ramachandran, P. Veeraraghavan, Blackburn, Thomas P., Ashby JR, Charles R.

    Published in Synapse (New York, N.Y.) (01-02-2007)
    “…We examined the effect of the administration of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine, citalopram, and paroxetine on the activity of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    5-ht6 receptors as emerging targets for drug discovery by Branchek, T A, Blackburn, T P

    “…5-ht6 receptors are the latest serotonin receptors to be identified by molecular cloning. Their high affinity for a wide range of drugs used in psychiatry,…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The acute and chronic administration of the 5-HT2B/2C receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study by Blackburn, Thomas P., Suzuki, Katsuaki, Ashby Jr, Charles R.

    Published in Synapse (New York, N.Y.) (15-06-2006)
    “…This study examined the effect of the acute and chronic administration of the 5‐HT2B/2C receptor antagonist N‐(1‐methyl‐5‐indolyl)‐N′‐(3‐pyridyl) urea…”
    Get full text
    Journal Article